Mechanisms of action of EGFR tyrosine kinase receptor incorporated in extracellular vesicles

Mechanisms of action of EGFR tyrosine kinase receptor incorporated in extracellular vesicles

EGFR and some of the cognate ligands extensively traffic in extracellular vesicles (EVs) from different biogenesis pathways. EGFR belongs to a family of four homologous tyrosine kinase receptors (TKRs). This family are one of the major drivers of cancer and is involved in several of the most frequen...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Zanetti-Domingues, LC, Martin-Fernandez, ML, Huber, V
Định dạng:	Journal article
Ngôn ngữ:	English
Được phát hành:	MDPI 2020

Những quyển sách tương tự

Mechanisms of Action of EGFR Tyrosine Kinase Receptor Incorporated in Extracellular Vesicles
Bằng: Laura C. Zanetti-Domingues, et al.
Được phát hành: (2020-11-01)

Cooperation and interplay between EGFR signalling and extracellular vesicle biogenesis in cancer
Bằng: Zanetti-Domingues, LC, et al.
Được phát hành: (2020)

Cooperation and Interplay between EGFR Signalling and Extracellular Vesicle Biogenesis in Cancer
Bằng: Laura C. Zanetti-Domingues, et al.
Được phát hành: (2020-12-01)

Extracellular Vesicles As Mediators of Resistance to EGFR-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Preclinical Models
Bằng: M. Pérez-Capó, et al.
Được phát hành: (2023-11-01)

Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
Bằng: Xu H, et al.
Được phát hành: (2019-07-01)

Mechanisms of resistance to EGFR tyrosine kinase inhibitors
Bằng: Lihua Huang, et al.
Được phát hành: (2015-09-01)

Depleting receptor tyrosine kinases EGFR and HER2 overcomes resistance to EGFR inhibitors in colorectal cancer
Bằng: Lu Yang, et al.
Được phát hành: (2022-06-01)

Radiation-Induced Tumor-Derived Extracellular Vesicles Combined with Tyrosine Kinase Inhibitors: An Effective and Safe Therapeutic Approach for Lung Adenocarcinoma with EGFR19Del
Bằng: Yao Li, et al.
Được phát hành: (2024-12-01)

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and IGF-1R
Bằng: Cornelius Hempel, et al.
Được phát hành: (2017-01-01)

Clinical activity of the EGFR tyrosine kinase inhibitor osimertinib in EGFR-mutant glioblastoma
Bằng: Igor Makhlin, et al.
Được phát hành: (2019-11-01)

An extracellular receptor tyrosine kinase motif orchestrating intracellular STAT activation
Bằng: Katri Vaparanta, et al.
Được phát hành: (2022-11-01)

Structural Insight and Development of EGFR Tyrosine Kinase Inhibitors
Bằng: Tasia Amelia, et al.
Được phát hành: (2022-01-01)

Extracellular vesicle-associated tyrosine kinase-like orphan receptors ROR1 and ROR2 promote breast cancer progression
Bằng: Barnabas Irmer, et al.
Được phát hành: (2023-07-01)

Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers
Bằng: Aude I. Ségaliny, et al.
Được phát hành: (2015-03-01)

Editorial: Discovery of EGFR tyrosine kinase inhibitors for cancer treatment
Bằng: Panupong Mahalapbutr, et al.
Được phát hành: (2024-02-01)

Extracellular Vesicles Act as Nano-Transporters of Tyrosine Kinase Inhibitors to Revert Iodine Avidity in Thyroid Cancer
Bằng: Ramya Lakshmi Rajendran, et al.
Được phát hành: (2021-02-01)

Moving the Needle Cautiously in Targeting One of the Most Often Acquired Receptor Tyrosine Fusion (RET Fusion) Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors
Bằng: Shannon S. Zhang, MD, et al.
Được phát hành: (2022-08-01)

Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with <i>EGFR</i> Mutations
Bằng: Kenichi Suda, et al.
Được phát hành: (2021-06-01)

Immunotherapy strategies for EGFR-mutated advanced NSCLC after EGFR tyrosine-kinase inhibitors failure
Bằng: Xingyuan Li, et al.
Được phát hành: (2023-10-01)

Mechanisms of receptor tyrosine kinase activation in cancer
Bằng: Zhenfang Du, et al.
Được phát hành: (2018-02-01)

Crystal structure of the Sema-PSI extracellular domain of human RON receptor tyrosine kinase.
Bằng: Kinlin L Chao, et al.
Được phát hành: (2012-01-01)

Action Mechanisms of Small Extracellular Vesicles in Inflammaging
Bằng: Rocío Mato-Basalo, et al.
Được phát hành: (2022-04-01)

Osimertinib – effective treatment of NSCLC with activating EGFR mutations after progression on EGFR tyrosine kinase inhibitors
Bằng: Marcin Skrzypski, et al.
Được phát hành: (2017-09-01)

Primary Resistance to EGFR Tyrosine Kinase Inhibitors (TKIs): Contexts and Comparisons in EGFR-Mutated Lung Cancer
Bằng: Keigo Kobayashi
Được phát hành: (2023-12-01)

BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations.
Bằng: Daniel B Costa, et al.
Được phát hành: (2007-10-01)

EGFR tyrosine kinase activity and Rab GTPases coordinate EGFR trafficking to regulate macrophage activation in sepsis
Bằng: Xuedi Zhang, et al.
Được phát hành: (2022-11-01)

Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer
Bằng: Zhe Zhang, et al.
Được phát hành: (2019-11-01)

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistance
Bằng: Tim Fischer, et al.
Được phát hành: (2018-01-01)

miR-494 in Extracellular Vesicles as a Potent Biomarker of Chronic Myeloid Leukemia Treatment with Tyrosine Kinase Inhibitors
Bằng: Tatsuki Shibuta, et al.
Được phát hành: (2022-06-01)

A preliminary results of integrated chemotherapy with EGFR receptor tyrosine kinase inhibitors in patients with non-small-cell-lung cancer harboring EGFR mutation
Bằng: K. K. Laktionov, et al.
Được phát hành: (2019-06-01)

Proteolytic Cleavage of Receptor Tyrosine Kinases
Bằng: Hao Huang
Được phát hành: (2021-04-01)

Receptor Tyrosine Kinases — Expanding Horizons
Bằng: Sassan Hafizi
Được phát hành: (2014-06-01)

Extracellular phosphorylation of a receptor tyrosine kinase controls synaptic localization of NMDA receptors and regulates pathological pain.
Bằng: Kenji Hanamura, et al.
Được phát hành: (2017-07-01)

Mechanisms of Activation of Receptor Tyrosine Kinases: Monomers or Dimers
Bằng: Ichiro N. Maruyama
Được phát hành: (2014-04-01)

In Vitro Activation and Inhibition of Recombinant EGFR Tyrosine Kinase Expressed in Escherichia coli
Bằng: Jihene Elloumi-Mseddi, et al.
Được phát hành: (2013-01-01)

Afatinib and Necitumumab in EGFR-Mutant NSCLC with Acquired Resistance to Tyrosine Kinase Inhibitors
Bằng: Nathaniel J. Myall, MD, et al.
Được phát hành: (2025-02-01)

ALGORITHMS FOR MANAGEMENT OF PATIENTS WITH ADVERSE EVENTS ON THERAPY WITH TYROSINE KINASE INHIBITORS EGFR
Bằng: D. D. SAKAEVA
Được phát hành: (2017-06-01)

Remodeling of tumor microenvironments by EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer
Bằng: Soomin Kim, et al.
Được phát hành: (2025-02-01)

The Prediction Of Epidermal Growth Factor Receptor Mutation And Prognosis Of EGFR Tyrosine Kinase Inhibitor By Serum Ferritin In Advanced NSCLC
Bằng: Wu Z, et al.
Được phát hành: (2019-10-01)

Durable response to EGFR tyrosine kinase inhibitors in a patient with non–small cell lung cancer harboring an EGFR kinase domain duplication
Bằng: Esuteru Hirokawa, et al.
Được phát hành: (2021-08-01)